Disc Medicine, Inc.
IRON
$41.25
-$4.53-9.89%
| Weiss Ratings | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.96 | |||
| Price History | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -21.20% | |||
| 30-Day Total Return | -24.15% | |||
| 60-Day Total Return | -33.29% | |||
| 90-Day Total Return | -34.87% | |||
| Year to Date Total Return | -33.77% | |||
| 1-Year Total Return | 40.20% | |||
| 2-Year Total Return | 95.19% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -33.41% | |||
| 52-Week Low % Change | 78.49% | |||
| Price | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $68.73 | |||
| 52-Week Low Price | $25.64 | |||
| 52-Week Low Price (Date) | Apr 26, 2024 | |||
| 52-Week High Price (Date) | Nov 11, 2024 | |||
| Valuation | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.58B | |||
| Enterprise Value | 1.12B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.98 | |||
| Earnings Per Share Growth | 14.18% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 3.08 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $41.36 | |||
| Enterprise Value/EBITDA (TTM) | -8.66 | |||
| Enterprise Value/EBIT | -8.65 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 30.00M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 617 674 9274 | |||
| Address | 321 Arsenal Street Watertown, MA 02472 | |||
| Website | www.discmedicine.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -18.75% | |||
| Return on Equity | -- | |||
| Income Statement | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -129.56M | |||
| EBIT (TTM) | -129.72M | |||
| Net Income (TTM) | -109.36M | |||
| Net Income Avl. to Common (TTM) | -109.36M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -24.93% | |||
| EPS Diluted (TTM) | -3.98 | |||
| EPS Diluted Growth (Q YOY) | -1.82% | |||
| Balance Sheet | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 489.88M | |||
| Cash Per Share (Q) | $16.33 | |||
| Total Current Assets (Q) | 493.62M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 443.59M | |||
| Current Ratio (Q) | 21.171 | |||
| Book Value Per Share (Q) | $14.85 | |||
| Total Assets (Q) | 496.77M | |||
| Total Current Liabilities (Q) | 23.32M | |||
| Total Debt (Q) | 30.00M | |||
| Total Liabilities (Q) | 53.19M | |||
| Total Common Equity (Q) | 443.59M | |||
| Cash Flow | IRON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -292.33M | |||
| Cash from Financing (TTM) | 218.31M | |||
| Net Change in Cash (TTM) | -167.94M | |||
| Levered Free Cash Flow (TTM) | -61.01M | |||
| Cash from Operations (TTM) | -93.93M | |||
